At-Home STI Testing Market Size, Share & Trends Analysis Report By Infection (HIV, CT), By Test Type (Molecular/NAAT-based Kits, Multiplex Panel Testing), By Sample Type, By Distribution Channel, By Region, And Segment Forecasts, 2026

The global at-home STI testing market size was estimated at USD 2.98 billion in 2025 and is projected to reach USD 5.86 billion by 2033, growing at a CAGR of 8.85% from 2026 to 2033. The rising prevalence of sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, and HIV, along with increasing awareness and demand for private, convenient testing solutions, is significantly driving market growth.

According to the World Health Organization, more than 1 million STIs are acquired every day worldwide, while the Centers for Disease Control and Prevention reports over 2.4 million cases of chlamydia, gonorrhea, and syphilis annually in the U.S. If left undiagnosed and untreated, STIs can lead to severe reproductive health complications, infertility, adverse pregnancy outcomes, and increased HIV transmission risk, underscoring the critical need for accessible screening solutions such as at-home STI testing.

The increasing number of regulatory clearances for fully at-home and over-the-counter STI diagnostic solutions is significantly accelerating market adoption. In March 2025, the U.S. Food and Drug Administration granted marketing authorization to Visby Medical's Women's Sexual Health Test, the first fully at-home diagnostic capable of detecting chlamydia, gonorrhea, and trichomoniasis with results in approximately 30 minutes. This milestone marks a major shift toward consumer-operated STI diagnostics, enabling rapid detection without laboratory visits and expanding access to accurate home-based testing.

Advancements in rapid self-testing technologies are further improving accessibility and speed of diagnosis. In October 2025, the FDA approved the INSTI HIV Self-Test from bioLytical Laboratories, a finger-stick blood test delivering results in about one minute, significantly reducing testing barriers and enabling immediate status awareness. In addition, continued availability of oral-fluid rapid tests such as OraQuick supports broader HIV screening uptake through painless, user-friendly self-testing options. These innovations enhance convenience and privacy, further driving consumer adoption.

Technological innovation in molecular and multiplex STI testing is expanding the clinical reliability and scope of home diagnostics. New home-collected molecular tests enable simultaneous detection of multiple infections from a single specimen, improving screening efficiency and patient compliance. For example, multiplex STI testing solutions capable of detecting infections such as chlamydia, gonorrhea, trichomoniasis, and Mycoplasma genitalium from one sample are being deployed through telehealth-enabled care pathways, improving comprehensive sexual health screening and follow-up care. The expansion of multiplex testing is increasing diagnostic accuracy while enhancing the value proposition of at-home screening.

Public health initiatives and digital health distribution programs are also expanding access to home STI testing among high-risk and underserved populations. Programs such as the CDC-supported Together TakeMeHome initiative have distributed hundreds of thousands of free at-home HIV self-tests across the U.S., improving early detection and reaching first-time testers. In parallel, governments and healthcare systems increasingly recognize home testing as a critical strategy to improve screening rates, reduce stigma barriers, and support early treatment. These initiatives are strengthening the role of at-home STI testing in preventive healthcare and disease control strategies.

However, factors such as concerns regarding diagnostic accuracy, improper sample collection, and user interpretation errors can affect test reliability, particularly for self-administered rapid tests, which are anticipated to restrain market growth. Reimbursement limitations and out-of-pocket costs may restrict adoption in price-sensitive markets, especially where public health programs primarily support clinic-based screening. Privacy concerns related to digital result reporting and telehealth integration also continue to influence consumer trust. Furthermore, variability in regulatory frameworks and quality standards across countries creates barriers for manufacturers seeking global expansion.

Global At-home STI Testing Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global at-home STI testing market report based on infection, test type, sample type, distribution channel, and region:

Infection Outlook (Revenue, USD Million, 2021 - 2033)
HIV
Chlamydia (CT)
Gonorrhea (NG)
Syphilis
Trichomoniasis
HPV
Hepatitis B & C
Others
Test Type Outlook (Revenue, USD Million, 2021 - 2033)
Rapid Lateral Flow Immunoassays
Molecular / NAAT-based Kits
Multiplex Panel Testing
Others
Sample Type Outlook (Revenue, USD Million, 2021 - 2033)
Blood
Urine
Oral Fluid/Saliva
Vaginal Swab
Others
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Online Pharmacies & D2C Platforms
Retail Pharmacies
Public Health Distribution Programs
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: GVR-4-68040-863-3

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Segment Definitions
- 1.2.1. Infection
- 1.2.2. Test Type
- 1.2.3. Sample Type
- 1.2.4. Distribution Channel
- 1.2.5. Regional Scope
- 1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. At-home STI Testing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Rising global prevalence of sexually transmitted infections (STIs)
  - 3.2.1.2. Increasing adoption of telehealth and digital sexual health services
  - 3.2.1.3. Growing demand for private, convenient, and stigma-free testing solutions
  - 3.2.1.4. Regulatory approvals and technological advancements in self-testing diagnostics
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Concerns regarding test accuracy and improper sample collection
  - 3.2.2.2. Limited reimbursement coverage and affordability constraints in emerging markets
3.3. At-home STI Testing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Technological landscape
  - 3.3.2.5. Environmental landscape
  - 3.3.2.6. Legal landscape

Chapter 4. At-home STI Testing Market: Infection Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. At-home STI Testing Market: Infection Movement Analysis
4.3. At-home STI Testing Market by Infection Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
4.5. HIV
- 4.5.1. HIV Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Chlamydia (CT)
- 4.6.1. Chlamydia (CT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Gonorrhea (NG)
- 4.7.1. Gonorrhea (NG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Syphilis
- 4.8.1. Syphilis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Trichomoniasis
- 4.9.1. Trichomoniasis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10. HPV
- 4.10.1. HPV Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11. Hepatitis B & C
- 4.11.1. Hepatitis B & C Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.12. Others
- 4.12.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. At-home STI Testing Market: Test Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. At-home STI Testing Market: Test Type Movement Analysis
5.3. At-home STI Testing Market by Test Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
5.5. Rapid Lateral Flow Immunoassays
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Molecular / NAAT-based Kits
- 5.6.1. Molecular / NAAT-based Kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Multiplex Panel Testing
- 5.7.1. Multiplex Panel Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
- 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. At-home STI Testing Market: Sample Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. At-home STI Testing Market: Sample Type Movement Analysis
6.3. At-home STI Testing Market by Sample Type Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
6.5. Blood
- 6.5.1. Blood Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Urine
- 6.6.1. Urine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Oral Fluid/Saliva
- 6.7.1. Oral Fluid/Saliva Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Vaginal Swab
- 6.8.1. Vaginal Swab Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Others
- 6.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. At-home STI Testing Market: Distribution Channel Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. At-home STI Testing Market: Distribution Channel Movement Analysis
7.3. At-home STI Testing Market by Distribution Channel Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
7.5. Online Pharmacies & D2C Platforms
- 7.5.1. Online Pharmacies & D2C Platforms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Retail Pharmacies
- 7.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Public Health Distribution Programs
- 7.7.1. Public Health Distribution Programs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Others
- 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. At-home STI Testing Market: Regional Estimates & Trend Analysis

8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2021 - 2033:
8.3. North America
- 8.3.1. U.S.
  - 8.3.1.1. Key country dynamics
  - 8.3.1.2. Regulatory framework/ reimbursement structure
  - 8.3.1.3. Competitive scenario
  - 8.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.2. Canada
  - 8.3.2.1. Key country dynamics
  - 8.3.2.2. Regulatory framework/ reimbursement structure
  - 8.3.2.3. Competitive scenario
  - 8.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Mexico
  - 8.3.3.1. Key country dynamics
  - 8.3.3.2. Regulatory framework/ reimbursement structure
  - 8.3.3.3. Competitive scenario
  - 8.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
8.4. Europe
- 8.4.1. UK
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Regulatory framework/ reimbursement structure
  - 8.4.1.3. Competitive scenario
  - 8.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.2. Germany
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Regulatory framework/ reimbursement structure
  - 8.4.2.3. Competitive scenario
  - 8.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.3. France
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Regulatory framework/ reimbursement structure
  - 8.4.3.3. Competitive scenario
  - 8.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.4. Italy
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Regulatory framework/ reimbursement structure
  - 8.4.4.3. Competitive scenario
  - 8.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.5. Spain
  - 8.4.5.1. Key country dynamics
  - 8.4.5.2. Regulatory framework/ reimbursement structure
  - 8.4.5.3. Competitive scenario
  - 8.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.6. Norway
  - 8.4.6.1. Key country dynamics
  - 8.4.6.2. Regulatory framework/ reimbursement structure
  - 8.4.6.3. Competitive scenario
  - 8.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.7. Sweden
  - 8.4.7.1. Key country dynamics
  - 8.4.7.2. Regulatory framework/ reimbursement structure
  - 8.4.7.3. Competitive scenario
  - 8.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.8. Denmark
  - 8.4.8.1. Key country dynamics
  - 8.4.8.2. Regulatory framework/ reimbursement structure
  - 8.4.8.3. Competitive scenario
  - 8.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
8.5. Asia Pacific
- 8.5.1. Japan
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Regulatory framework/ reimbursement structure
  - 8.5.1.3. Competitive scenario
  - 8.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.2. China
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework/ reimbursement structure
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.3. India
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory framework/ reimbursement structure
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.4. Australia
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Regulatory framework/ reimbursement structure
  - 8.5.4.3. Competitive scenario
  - 8.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.5. South Korea
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Regulatory framework/ reimbursement structure
  - 8.5.5.3. Competitive scenario
  - 8.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.6. Thailand
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Regulatory framework/ reimbursement structure
  - 8.5.6.3. Competitive scenario
  - 8.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
8.6. Latin America
- 8.6.1. Brazil
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Regulatory framework/ reimbursement structure
  - 8.6.1.3. Competitive scenario
  - 8.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.6.2. Argentina
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework/ reimbursement structure
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
8.7. MEA
- 8.7.1. South Africa
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Regulatory framework/ reimbursement structure
  - 8.7.1.3. Competitive scenario
  - 8.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.2. Saudi Arabia
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework/ reimbursement structure
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.3. UAE
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Regulatory framework/ reimbursement structure
  - 8.7.3.3. Competitive scenario
  - 8.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.4. Kuwait
  - 8.7.4.1. Key country dynamics
  - 8.7.4.2. Regulatory framework/ reimbursement structure
  - 8.7.4.3. Competitive scenario
  - 8.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
9.2. Recent Developments & Impact Analysis by Key Market Participants
9.3. Company Market Share Analysis, 2025
9.4. Key Company Profiles
- 9.4.1. OraSure Technologies Inc.
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Abbott
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. bioLytical Laboratories Inc.
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Chembio Diagnostics, Inc.
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. BD (Becton Dickinson)
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. LetsGetChecked
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. Everlywell
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. NURX Inc.
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. Hologic, Inc.
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product benchmarking
  - 9.4.9.4. Strategic initiatives

Product Code: GVR-4-68040-863-3

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 4 Global at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 5 Global at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 6 Global at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 7 North America At-home STI Testing market, by region, 2021 - 2033 (USD Million)
Table 8 North America at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 9 North America at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 10 North America at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 11 North America at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 12 U.S. at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 13 U.S. at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 14 U.S. at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 15 U.S. at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 16 Canada at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 17 Canada at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 18 Canada at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 19 Canada at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 20 Mexico at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 21 Mexico at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 22 Mexico at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 23 Mexico at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 24 Europe at-home STI testing market, by country, 2021 - 2033 (USD Million)
Table 25 Europe at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 26 Europe at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 27 Europe at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 28 Europe at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 29 UK at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 30 UK at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 31 UK at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 32 UK at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 33 Germany at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 34 Germany at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 35 Germany at-home STI testing market, by sample type 2021 - 2033 (USD Million)
Table 36 Germany at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 37 France at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 38 France at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 39 France at-home STI testing market, by sample type 2021 - 2033 (USD Million)
Table 40 France at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 41 Italy at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 42 Italy at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 43 Italy at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 44 Italy at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 45 Spain at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 46 Spain at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 47 Spain at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 48 Spain at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 49 Denmark at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 50 Denmark at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 51 Denmark at-home STI testing market, by sample type 2021 - 2033 (USD Million)
Table 52 Denmark at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 53 Sweden at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 54 Sweden at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 55 Sweden at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 56 Sweden at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 57 Norway at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 58 Norway at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 59 Norway at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 60 Norway at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 61 Asia Pacific at-home STI testing market, by country, 2021 - 2033 (USD Million)
Table 62 Asia Pacific at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 63 Asia Pacific at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 64 Asia Pacific at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 65 Asia Pacific at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 66 Japan at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 67 Japan at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 68 Japan at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 69 Japan at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 70 China at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 71 China at-home STI testing market, by test type 2021 - 2033 (USD Million)
Table 72 China at-home STI testing market, by sample type 2021 - 2033 (USD Million)
Table 73 China at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 74 India at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 75 India at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 76 India at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 77 India at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 78 Australia at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 79 Australia at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 80 Australia at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 81 Australia at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 82 South Korea at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 83 South Korea at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 84 South Korea at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 85 South Korea at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 86 Thailand at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 87 Thailand at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 88 Thailand at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 89 Thailand at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 90 Latin America at-home STI testing market, by country, 2021 - 2033 (USD Million)
Table 91 Latin America at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 92 Latin America at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 93 Latin America at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 94 Latin America at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 95 Brazil at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 96 Brazil at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 97 Brazil at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 98 Brazil at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 99 Argentina at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 100 Argentina at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 101 Argentina at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 102 Argentina at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 103 Middle East & Africa at-home STI testing market, by country, 2021 - 2033 (USD Million)
Table 104 Middle East & Africa at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 105 Middle East & Africa at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 106 Middle East & Africa at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 107 Middle East & Africa at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 108 South Africa at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 109 South Africa at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 110 South Africa at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 111 South Africa at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 112 Saudi Arabia at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 116 UAE at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 117 UAE at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 118 UAE at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 119 UAE at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)
Table 120 Kuwait at-home STI testing market, by infection, 2021 - 2033 (USD Million)
Table 121 Kuwait at-home STI testing market, by test type, 2021 - 2033 (USD Million)
Table 122 Kuwait at-home STI testing market, by sample type, 2021 - 2033 (USD Million)
Table 123 Kuwait at-home STI testing market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 At-home STI Testing market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 10 Porter's five forces analysis
Fig. 11 At-home STI testing market, infection outlook key takeaways, 2025 & 2033 (USD Million)
Fig. 12 At-home STI testing market, infection movement analysis, 2025 & 2033 (USD Million)
Fig. 13 HIV market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Chlamydia (CT) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 15 Gonorrhea (NG) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 16 Syphilis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 17 Trichomoniasis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 18 HPV market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 19 Hepatitis B & C market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 At-home STI testing market, test type outlook key takeaways, 2025 & 2033 (USD Million)
Fig. 22 At-home STI testing market, test type movement analysis, 2025 & 2033 (USD Million)
Fig. 23 Rapid lateral flow immunoassays market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Molecular / NAAT-based Kits market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Multiplex panel testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 At-home STI testing market, sample type outlook key takeaways, 2025 & 2033 (USD Million)
Fig. 28 At-home STI testing market, sample type movement analysis, 2025 & 2033 (USD Million)
Fig. 29 Blood market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Urine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Oral fluid/Saliva market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Vaginal swab market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 At-home STI testing market, distribution channel outlook key takeaways, 2025 & 2033 (USD Million)
Fig. 35 At-home STI testing market, distribution channel movement analysis, 2025 & 2033 (USD Million)
Fig. 36 Online pharmacies & D2C platforms market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Retail pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Public health distribution programs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 North America at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 US at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Canada at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Mexico at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Europe at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 UK at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Germany at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 France at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Spain at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Italy at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Denmark at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Sweden at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Norway at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Asia Pacific at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 China at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Japan at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 India at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 South Korea at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Australia at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Thailand at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Latin America at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Brazil at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Argentina at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 Middle East and Africa at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 South Africa at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Saudi Arabia at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 66 UAE at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Kuwait at-home STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 List of key emerging companies

At-Home STI Testing Market Size, Share & Trends Analysis Report By Infection (HIV, CT), By Test Type (Molecular/NAAT-based Kits, Multiplex Panel Testing), By Sample Type, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

Description

Table of Contents

List of Tables

At-Home STI Testing Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. At-home STI Testing Market Variables, Trends & Scope

Chapter 4. At-home STI Testing Market: Infection Estimates & Trend Analysis

Chapter 5. At-home STI Testing Market: Test Type Estimates & Trend Analysis

Chapter 6. At-home STI Testing Market: Sample Type Estimates & Trend Analysis

Chapter 7. At-home STI Testing Market: Distribution Channel Estimates & Trend Analysis

Chapter 8. At-home STI Testing Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures